Emerging T cell immunoregulatory mechanisms in multiple sclerosis and Alzheimer’s disease
Multiple sclerosis (MS) and Alzheimer’s disease (AD) are neuroinflammatory and neurodegenerative diseases with considerable socioeconomic impacts but without definitive treatments. AD and MS have multifactorial pathogenesis resulting in complex cognitive and neurologic symptoms and growing evidence...
| Huvudupphovsman: | Daniel Hawiger |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Frontiers Media S.A.
2024-02-01
|
| Serie: | Frontiers in Aging Neuroscience |
| Ämnen: | |
| Länkar: | https://www.frontiersin.org/articles/10.3389/fnagi.2024.1350240/full |
Liknande verk
Liknande verk
-
Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases
av: Courtney A. Iberg, et al.
Publicerad: (2020-06-01) -
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
av: Caiyun Liu, et al.
Publicerad: (2022-12-01) -
Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
av: Barbara Rossi, et al.
Publicerad: (2021-02-01) -
CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment
av: Audrey Abecassis, et al.
Publicerad: (2022-08-01) -
Targeting Antigen-Presenting Cells in Multiple Sclerosis Treatment
av: Piotr Szpakowski, et al.
Publicerad: (2021-09-01)